EFFECTS OF NIFEDIPINE SR AND ENALAPRIL ON OFFICE, HOME AND AMBULATORY BLOOD-PRESSURE IN WHITE-COAT SYSTEMIC HYPERTENSION

被引:18
作者
ASHIDA, T [1 ]
ABE, H [1 ]
KAWANO, Y [1 ]
YOSHIDA, K [1 ]
KIMURA, G [1 ]
KOJIMA, S [1 ]
YOSHIMI, H [1 ]
KAWAMURA, M [1 ]
IMANISHI, M [1 ]
SANAI, T [1 ]
KURAMOCHI, M [1 ]
OMAE, T [1 ]
机构
[1] NATL CARDIOVASC CTR,DEPT MED,DIV NEPHROL,SUITA,OSAKA 565,JAPAN
关键词
D O I
10.1016/0002-9149(90)90713-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among patients who were found to have hypertension by office or clinic blood pressure (BP) measurement, some appear to be normotensive when studied for full 24-hour periods by ambulatory BP monitoring, indicating so-called "office" or "white-coat" hypertension. Within groups of hypertensive patients with similar office BPs, those with higher than predicted ambulatory BP have greater prevalence of target-organ damage1,2 and a significantly greater 10-year incidence of fatal and unfatal events than those with lower than predicted ambulatory BP.3 Moreover, there is some indication that reducing BP too much may exert a deleterious rather than a beneficial effect on coronary events.4 In the present study, we examined and compared the effects of the long-acting calcium antagonist nifedipine slow-release tablet (nifedipine SR) with the effects of the long-acting angiotensin converting enzyme inhibitor enalapril on office, home and ambulatory BP measurements. We studied hypertensive patients with relatively higher and relatively lower ambulatory BPs. © 1990.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 12 条
  • [1] HEMODYNAMIC EFFECTS OF A CALCIUM ANTAGONISTIC AGENT (NIFEDIPINE) IN HYPERTENSION - THERAPEUTIC IMPLICATIONS
    BARTORELLI, C
    MAGRINI, F
    MORUZZI, P
    OLIVARI, MT
    POLESE, A
    FIORENTINI, C
    GUAZZI, M
    [J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 : S291 - S292
  • [2] CRUICKSHANK JM, 1987, LANCET, V1, P581
  • [3] NIFEDIPINE - INDIVIDUAL-RESPONSES AND CONCENTRATION-EFFECT RELATIONSHIPS
    DONNELLY, R
    ELLIOTT, HL
    MEREDITH, PA
    KELMAN, AW
    REID, JL
    [J]. HYPERTENSION, 1988, 12 (04) : 443 - 449
  • [4] ERNE P, 1983, HYPERTENSION, V5, P97
  • [5] AGE, RACE, BLOOD-PRESSURE AND RENIN - PREDICTORS FOR ANTIHYPERTENSIVE TREATMENT WITH CALCIUM-ANTAGONISTS
    KIOWSKI, W
    BUHLER, FR
    FADAYOMI, MO
    ERNE, P
    MULLER, FB
    HULTHEN, UL
    BOLLI, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (16) : H81 - H85
  • [6] KURIYAMA Y, 1989, SHOULD ELDERLY HYPER, P69
  • [7] MACGREGOR GA, 1982, J CARDIOVASC PHARM, V4, pS358
  • [8] DOES THE RENIN-ANGIOTENSIN SYSTEM MAINTAIN BLOOD-PRESSURE IN BOTH HYPERTENSIVE AND NORMOTENSIVE SUBJECTS - COMPARISON OF PROPRANOLOL, SARALASIN AND CAPTOPRIL
    MACGREGOR, GA
    MARKANDU, ND
    ROULSTON, JE
    [J]. CLINICAL SCIENCE, 1979, 57 : S145 - S148
  • [9] THE PROGNOSTIC VALUE OF AMBULATORY BLOOD PRESSURES
    PERLOFF, D
    SOKOLOW, M
    COWAN, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (20): : 2792 - 2798
  • [10] SOKOLOW M, 1966, CIRCULATION, V34, P279